Does a High BMI Affect Supervised Pelvic Floor Muscle Training for Improving Symptoms in Women With Various Stages of Pelvic Organ Prolapse?
NCT ID: NCT04009694
Last Updated: 2019-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2018-09-01
2019-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Candidates will be selected via a convenience sampling method from four physiotherapy outpatient departments at a NHS trust within Greater Manchester. The data collection occurred in January-June 2019 and ethical approval was granted by School Research Ethics, University of Salford.
Treatment aims to ensure there is respect for their autonomy, treatment is fair (Justice), no harm is done to the participant (nonmaleficence) and treatment benefits the participants (beneficence).
Participants are required to complete a consent form prior to their initial session. To ensure methodological quality, the STROBE guidelines will be followed to make certain all apt information required is reported to allow for replication of the intervention.
The trial aims to include (n=60) women with a diagnosed pelvic organ prolapse. They are required to complete 16 weeks of supervised pelvic floor exercises with a specialist physiotherapist as documented within the most recent NICE guidelines.
The outcome measures used will be the Pelvic Organ Prolapse symptom score (POPSS) and this will be documented before and after the 16 week period.
Along side the POPSS, the patients body mass index and severity of pelvic organ prolapse will also be recorded and the results of this will be correlated post trial using the relevant data analysis testing methods.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Effects of Physiotherapy to Prevent Pelvic Organ Prolapse
NCT01171846
Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse
NCT00476892
Effects of the Hypopressive Exercises in Women With Pelvic Organ Prolapse
NCT06352112
Does Doing Pelvic Floor Exercise Ease Symptoms for Women Living With Prolapse?
NCT00158626
Pelvic Floor Muscle Training and Hypopressive Exercises for Pelvic Organ Prolapse
NCT01196598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pelvic Floor Muscle Training
Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist.
Participants will be assessed at weeks 0 / 4 / 10 \& 16 and the outcome measures will be recorded at week 0 \& week 16.
During each assessment, participants will be educated regarding the anatomy of pelvic organ prolapses and the pelvic floor muscles. They will be taught how to contract their pelvic floor, offered a vaginal examination, given a personalised pelvic floor muscle training programme (including the Knack) - up to a ten second hold long contractions (x 10 repitations) and up to 10 quick contractions. They will also be taught a sub max contraction for up to 30 seconds, offered lifestyle management advice including avoiding heavy lifting or straining. A leaflet explaining the aforementioned information will also be provided at the initial assessment.
Pelvic Floor Muscle training
Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pelvic Floor Muscle training
Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>18 years old
Exclusion Criteria
* Unable to contract the pelvic floor muscles (determined by the treating physiotherapist)
* History of Pelvic cancer / or radiotherapy treatment within three months,
* Neurological or psychiatric disorders,
* Untreated urinary tract infections,
* Pregnant or planning to become pregnant or given birth within the past year,
* Recent vaginal surgery within twelve weeks or evidence of genital oedema,
* Suspected infection or fragility of the genital area As indicated by the referral source or patient reported at the initial assessment.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Salford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Whittle
Rebecca Whittle BSc Hons. Specialist Pelvic Health Physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicky Spence, PhD
Role: STUDY_CHAIR
University of Salford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Health Service
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USalford1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.